ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Releases New Drug Safety Communication on Gabapentin, Pregabalin
December 23, 2019The U.S. Food and Drug Administration (FDA) is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) ... -
Gabapentin, Opioids a Deadly Duo: FDA
December 20, 2019New warnings about the risk of dangerous breathing difficulties when gabapentinoids are used with opioids or by certain patients must now appear on product labels ... -
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users
June 14, 2019Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users. -
Pfizer loses landmark second medical use patent case
November 19, 2018The UK Supreme Court has ruled against Pfizer in a long-running legal battle over the validity of a second medical use patent protecting pregabalin.
Pharma Sources Insight January 2025
